The Plasmodial Surface Anion Channel And Malaria Parasite Nutrient Acquisition
疟原虫表面阴离子通道与疟原虫营养获取
基本信息
- 批准号:7964438
- 负责人:
- 金额:$ 67.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AffinityAllelesAnionsAntibodiesBaculovirusesBasic ScienceBehaviorBiochemicalBiologicalBiological AssayCell membraneCellsCellular biologyChemistryCollectionComplexCytolysisDependenceErythrocytesExhibitsFamilyFurosemideGene FamilyGenesGeneticGenetic CrossesGoalsGrowthHumanImmune SeraImmunoprecipitationInformaticsInheritedInsectaIntegral Membrane ProteinIon ChannelIon TransportIsotonic ExerciseLaboratoriesLipid BiochemistryLiposomesMalariaMeasurementMediatingMeiosisMembraneMembrane ProteinsModelingMolecularMolecular and Cellular BiologyNutrientParasitesParentsPathway interactionsPeptide HydrolasesPermeabilityPhysiologyPlasmaPlasmodium falciparumPrimatesPropertyProteinsRoleRouteSignal TransductionSorbitolSpecificityStructure-Activity RelationshipSurfaceSystemTemperatureTherapeuticTransmembrane DomainTransmembrane TransportWorkbasegene cloninghigh throughput screeninginhibitor/antagonistinterestnovelpatch clamppressureprotein purificationreconstitutionsmall molecule librariessolutevector
项目摘要
The Apicomplexan Molecular Physiology Section continued its studies of the plasmodial surface anion channel (PSAC) and made two significant contributions.
First, we identified stable differences in furosemide efficacy against PSAC activity induced by two common laboratory isolates of P. falciparum, HB3 and 3D7A. This difference was apparent in both single PSAC patch-clamp recordings and in sorbitol-mediated osmotic lysis measurements, confirming that Cl- and sorbitol are transported by a single channel type. HB3 and 3D7A are the parents of a previously executed genetic cross, permitting examination of how the difference in furosemide affinity is inherited by the progeny of this cross. We examined 19 progeny and found complex, non-Mendelian inheritance with some cloned progeny exhibiting furosemide affinities outside the range of parental values. Isolates generated by selfing of the 3D7A clone also exhibited altered furosemide affinities, implicating changes in one or more alleles during meiosis or passage through a primate host. PSAC may be encoded by multiple parasite genes (e.g. a multi-gene family or multiple genes that encode distinct channel subunits) or a single polymorphic gene under strong selective pressure.
Second, we have studied how PSAC recognizes and transports a diverse collection of nutrients and inorganic solutes. Despite this broad range of substrates, this channel nevertheless excludes Na+, a feature required to maintain erythrocyte osmotic stability in plasma. Another surprising property of PSAC is its small single-channel conductance (<3 pS in isotonic Cl-) in spite of broad permeability to bulky solutes. While exploring the mechanisms underlying these properties, we identified interactions between permeating solutes and PSAC inhibitors that suggest the channel has more than one route for passage of solutes. 22 structurally diverse solutes were studied with a quantitative osmotic lysis assay. These studies determined that two clearly separated groups of solutes based on their effects on inhibitor affinity, the temperature dependence of these effects and behavior in permeant solute mixtures. The clear separation into two discrete groups suggests two distinct mechanisms of transport through this channel. In contrast to most other broad-permeability channels, selectivity in PSAC appears to be complex and cannot be adequately explained by simple models that invoke sieving through rigid, non-interacting pores.
In addition to our studies on PSAC, we have identified a family of three novel integral membrane proteins colocalizing on the inner membrane complex immediately beneath the merozoite plasma membrane. These proteins are interesting because very few polytopic membrane proteins are known to be present in merozoites. Each of these proteins has six predicted transmembrane domains and is conserved in diverse apicomplexan parasites. Immunoprecipitation studies using specific antibodies reveal that these proteins assemble into a heteromeric complex. Each protein was also expressed on insect cells using the baculovirus vector system with a truncated SUMO tag that facilitates maximal expression and protein purification while permitting cleavage with SUMO protease to release unmodified parasite protein. The expressed proteins were successfully reconstituted into artificial liposomes, but were not recognized by human immune sera. Because all three genes are highly conserved in apicomplexan parasites, the complex formed by their encoded proteins likely serves an essential role for invasive merozoites; possibilities include signal transduction or transmembrane transport.
顶复门分子生理学组继续研究疟原虫表面阴离子通道(PSAC),并作出了两项重大贡献。
首先,我们确定了呋塞米对两种常见的恶性疟原虫实验室分离株HB 3和3D 7A诱导的PSAC活性的疗效的稳定差异。这种差异是明显的,在这两个单一的PSAC膜片钳记录和山梨醇介导的渗透溶解测量,确认Cl-和山梨醇通过一个单一的通道类型运输。HB 3和3D 7A是先前执行的遗传杂交的亲本,允许检查呋塞米亲和力的差异如何被该杂交的后代遗传。我们检查了19个后代,发现复杂的,非孟德尔遗传与一些克隆后代表现出呋塞米亲和力的范围外的亲本值。通过3D 7A克隆自交产生的分离物也表现出改变的呋塞米亲和力,暗示减数分裂或通过灵长类宿主期间一个或多个等位基因的变化。PSAC可以由多个寄生虫基因(例如多基因家族或编码不同通道亚基的多个基因)或在强选择压力下的单个多态性基因编码。
其次,我们研究了PSAC如何识别和运输多种营养物质和无机溶质。 尽管底物范围很广,但该通道仍然排除了Na+,这是维持血浆中红细胞渗透稳定性所需的特征。PSAC的另一个令人惊讶的性质是其小的单通道电导(在等渗Cl-中<3 pS),尽管对大体积溶质具有宽的渗透性。在探索这些特性的机制时,我们确定了渗透溶质和PSAC抑制剂之间的相互作用,这表明通道具有不止一种溶质通过的途径。 用定量渗透溶解试验研究了22种结构不同的溶质。 这些研究确定了两组明显分离的溶质,基于它们对抑制剂亲和力的影响,这些影响的温度依赖性和渗透性溶质混合物中的行为。明显分离为两个离散的组表明通过该通道的两种不同的运输机制。与大多数其他宽渗透性通道相反,PSAC中的选择性似乎是复杂的,并且不能通过简单的模型来充分解释,该模型通过刚性的、非相互作用的孔来进行筛选。
除了我们对PSAC的研究,我们已经确定了一个家庭的三个新的整合膜蛋白共定位于内膜复合物紧下面的裂殖子质膜。 这些蛋白是有趣的,因为很少有多位膜蛋白是已知的裂殖子中存在。 这些蛋白质中的每一个都具有六个预测的跨膜结构域,并且在不同的顶复门寄生虫中是保守的。使用特异性抗体的免疫沉淀研究表明,这些蛋白质组装成异聚复合物。还使用具有截短的SUMO标签的杆状病毒载体系统在昆虫细胞上表达每种蛋白,所述截短的SUMO标签促进最大表达和蛋白纯化,同时允许用SUMO蛋白酶切割以释放未修饰的寄生虫蛋白。表达的蛋白成功地重组到人工脂质体中,但不被人免疫血清识别。由于这三个基因在顶复门寄生虫中高度保守,因此它们编码的蛋白质形成的复合物可能对侵入性裂殖子起重要作用;可能性包括信号转导或跨膜转运。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SANJAY A DESAI其他文献
SANJAY A DESAI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SANJAY A DESAI', 18)}}的其他基金
EXPRESSION OF THE PLASMODIAL NUTRIENT CHANNEL ON OOCYTES
卵母细胞上疟原虫营养通道的表达
- 批准号:
2057456 - 财政年份:1994
- 资助金额:
$ 67.02万 - 项目类别:
EXPRESSION OF THE PLASMODIAL NUTRIENT CHANNEL ON OOCYTES
卵母细胞上疟原虫营养通道的表达
- 批准号:
2057455 - 财政年份:1994
- 资助金额:
$ 67.02万 - 项目类别:
EXPRESSION OF THE PLASMODIAL NUTRIENT CHANNEL ON OOCYTES
卵母细胞上疟原虫营养通道的表达
- 批准号:
2057457 - 财政年份:1994
- 资助金额:
$ 67.02万 - 项目类别:
The Plasmodial Surface Anion Channel And Malaria Parasite Nutrient Acquisition
疟原虫表面阴离子通道与疟原虫营养获取
- 批准号:
7592254 - 财政年份:
- 资助金额:
$ 67.02万 - 项目类别:
The Plasmodial Surface Anion Channel And Malaria Parasite Nutrient Acquisition
疟原虫表面阴离子通道与疟原虫营养获取
- 批准号:
8946347 - 财政年份:
- 资助金额:
$ 67.02万 - 项目类别:
The Plasmodial Surface Anion Channel And Malaria Parasite Nutrient Acquisition
疟原虫表面阴离子通道与疟原虫营养获取
- 批准号:
7732557 - 财政年份:
- 资助金额:
$ 67.02万 - 项目类别:
The Plasmodial Surface Anion Channel And Malaria Parasit
疟原虫表面阴离子通道与疟原虫
- 批准号:
6809114 - 财政年份:
- 资助金额:
$ 67.02万 - 项目类别:
Cellular and Molecular Physiology of Bloodstream Malaria Parasites
血流疟原虫的细胞和分子生理学
- 批准号:
10272080 - 财政年份:
- 资助金额:
$ 67.02万 - 项目类别:
Plasmodial Surface Anion Channel And Malaria Parasite
疟原虫表面阴离子通道与疟原虫
- 批准号:
6503692 - 财政年份:
- 资助金额:
$ 67.02万 - 项目类别:
The Plasmodial Surface Anion Channel And Malaria Parasite Nutrient Acquisition
疟原虫表面阴离子通道与疟原虫营养获取
- 批准号:
8336147 - 财政年份:
- 资助金额:
$ 67.02万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 67.02万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 67.02万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 67.02万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 67.02万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 67.02万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 67.02万 - 项目类别:
Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 67.02万 - 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 67.02万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 67.02万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 67.02万 - 项目类别: